Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2015
03/05/2015WO2015031914A1 Store overload-induced calcium release inhibitors and methods for producing and using the same
03/05/2015WO2015031824A1 Cyclic vinylogous amides as bromodomain inhibitors
03/05/2015WO2015031819A1 Modularly assembled small molecules for the treatment of myotonic dystrophy type 1
03/05/2015WO2015031765A2 Intermediate metabolism products to potentiate aminoglycoside antibiotics in bacterial infections
03/05/2015WO2015031759A1 Methods and compositions for re-activating epstein-barr virus and screening compounds therefor
03/05/2015WO2015031756A1 Novel 2,4-dinitrophenol formulations and methods using same
03/05/2015WO2015031753A1 Synthesis of alkylfurans
03/05/2015WO2015031741A1 Deuterated derivatives of a thienotriazolodiazapine bromodomain-containing protein inhibitor
03/05/2015WO2015031722A1 Method for treating amyotrophic lateral sclerosis by inhibition of cxcr4/cxcl12 signaling
03/05/2015WO2015031710A1 Compositions and methods for the treatment of metabolic and body weight related disorders
03/05/2015WO2015031709A1 Rapid acting injectable formulations comprising a peptide and a vasodilatory agent
03/05/2015WO2015031666A1 Combination of an alk inhibitor and a cdk inhibitor for the treatment of cell proliferative diseases
03/05/2015WO2015031650A1 Heterocyclic compounds and methods of use
03/05/2015WO2015031637A1 Nutritional composition having lipophilic compounds with improved solubility and bioavailability
03/05/2015WO2015031613A1 Biaryl acetamide compounds and methods of use thereof
03/05/2015WO2015031608A1 Substituted indole mcl-1 inhibitors
03/05/2015WO2015031598A2 Therapeutic dnp derivatives and methods using same
03/05/2015WO2015031595A1 A process for preparation of saxagliptin and its hydrochloride salt
03/05/2015WO2015031562A1 PROCESS FOR THE PREPARATION OF N,N-DICYCLOPROPYL-4-(1,5-DIMETHYL-1H-PYRAZOL-3-YLAMINO)-6-ETHYL-1-METHYL-1,6-DIHYDROIMIDAZO[4,5-d]PYRROLO[2,3-b]PYRIDINE-7-CARBOXAMIDE
03/05/2015WO2015031552A1 Estradiol containing transdermal drug delivery systems and compositions
03/05/2015WO2015031425A1 Compound of glycosaminoglycan and its preparation method as well as application
03/05/2015WO2015031413A2 Transdermal delivery of anastrozole for systemic effect
03/05/2015WO2015031412A1 Testosterone booster transdermal compositions
03/05/2015WO2015031410A1 Single-layer oral dose of neuro-attenuating ketamine
03/05/2015WO2015031405A1 Formulations of aminoglycosides and fosfomycin in a combination having improved chemical properties
03/05/2015WO2015031396A1 Pharmaceutical compositions comprising macrolide diastereomers, methods of their synthesis and therapeutic uses
03/05/2015WO2015031393A1 Treatment of pediatric otic disorders
03/05/2015WO2015031381A1 Cyclosporin analogues for preventing or treating hepatitis c
03/05/2015WO2015031300A1 Antibacterial beta-lactones, and methods of identification, manufacture and use
03/05/2015WO2015031295A1 Ido inhibitors
03/05/2015WO2015031285A1 Crystalline 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde ansolvate salts
03/05/2015WO2015031284A1 Formulations comprising wetting agents and compounds for the modulation of hemoglobin (s)
03/05/2015WO2015031198A2 Bendamustine pharmaceutical compositions
03/05/2015WO2015031186A1 Compositions and methods for the treatment of presbyopia
03/05/2015WO2015031183A1 Compositions and methods for the treatment of nasal conditions
03/05/2015WO2015031109A1 Inhibition of wnt, tgf beta and hippo signaling pathways to treat cancer, organ fibrosis and metabolic disorders
03/05/2015WO2015031036A1 Azaspiro[4.5] decane derivatives and use thereof
03/05/2015WO2015030854A1 Solid dispersion formulation of an antiviral compound
03/05/2015WO2015030853A1 Combination formulation of two antiviral compounds
03/05/2015WO2015030711A1 New use
03/05/2015WO2015030514A1 Tetrahydrocyclopentapyrrole derivative and preparation method therefor
03/05/2015WO2015030504A1 Pharmaceutical composition for prevention or treatment of toxoplasmosis, comprising anti-non-small cell lung cancer agent as active ingredient
03/05/2015WO2015030422A1 Composition for accelerating hair restoration or hair growth, comprising 21-o-angeloyltheasapogenol e3
03/05/2015WO2015030328A1 Compositions for preventing or treating allergic skin disorders, containing gpcr19 agents as active ingredients
03/05/2015WO2015030250A1 Pharmaceutical composition for treatment and/or prevention of pulmonary disease
03/05/2015WO2015030197A1 Novel microbial product having antifungal activity
03/05/2015WO2015030189A1 Novel aromatic compound and use thereof
03/05/2015WO2015030106A1 Compound having ggt inhibitory effect, and ggt-family enzyme inhibitor
03/05/2015WO2015030078A1 Therapeutic agent for ectocornea injury
03/05/2015WO2015030057A1 Novel morpholine derivative or salt thereof
03/05/2015WO2015030033A1 Therapeutic agent for dyslipidemia
03/05/2015WO2015030021A1 Pharmaceutical composition having pyrimidine compound as active ingredient
03/05/2015WO2015029968A1 Clock gene expression level modifier
03/05/2015WO2015029966A1 ω3 UNSATURATED FATTY ACID ENZYME AND METHOD FOR PRODUCING EICOSAPENTAENOIC ACID
03/05/2015WO2015029948A1 Prophylactic or therapeutic agent for retinal disease caused by retinal pigment epithelium disorder
03/05/2015WO2015029926A1 Ophthalmological composition
03/05/2015WO2015029925A1 Prophylactic, ameliorative, or therapeutic agent for retinopathy
03/05/2015WO2015029924A1 Ophthalmological composition
03/05/2015WO2015029923A1 Ophthalmological preparation
03/05/2015WO2015029473A1 Compound, medicine, anti-inflammatory, cosmetic, food and drink, and method for producing compound
03/05/2015WO2015029169A1 Javanese ginger extract and method for producing same
03/05/2015WO2015029134A1 Ginsenoside composition
03/05/2015WO2015029066A1 Polymorphic form of pyrrole derivative and intermediate thereof
03/05/2015WO2015029056A1 A bacterial vaccine and methods for manufacture thereof
03/05/2015WO2015029051A1 Pyrazolochalcones as potential anticancer agents
03/05/2015WO2015029035A1 SELECTIVE INHIBITORS OF α2 ISOFORM OF Na,K-ATPase AND USE FOR REDUCTION OF INTRA-OCULAR PRESSURE
03/05/2015WO2015028972A1 Pulsatile-release dosage form
03/05/2015WO2015028960A1 Substituted heterocyclic derivatives as gpr agonists and uses thereof
03/05/2015WO2015028956A1 Compositions and methods for the treatment of fatty acid oxidation disorders
03/05/2015WO2015028941A1 New use
03/05/2015WO2015028938A1 Substituted naphthalene compounds as calcium sensing receptor modulators
03/05/2015WO2015028929A1 Compounds and composition for use in the inhibition of the lbc-rhoa interaction, in particular for the treatment of cancer
03/05/2015WO2015028927A1 Compositions and methods for the treatment of metabolic diseases
03/05/2015WO2015028919A1 Agent for the treatment and prevention of cancer
03/05/2015WO2015028875A2 Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir and a monolithic tablet comprising darunavir and ritonavir
03/05/2015WO2015028850A1 Novel cytotoxic agents for conjugation of drugs to cell binding molecule
03/05/2015WO2015028848A1 Bicyclic heterocyclic compounds as multi-kinase inhibitors
03/05/2015WO2015028831A1 Cxcl12 (chemokine (c-x-c motif) ligand 12) and igfbp2 inhibitors for the application in the treatment of diabetes mellitus associated pancreatic cancer
03/05/2015WO2015028828A1 Sorafenib salts
03/05/2015WO2015028788A1 Composition and method for inducing or stimulating growth of keratinous fibres
03/05/2015WO2015028673A1 Cav3 CHANNEL BLOCKING AGENT FOR PAIN TREATMENT
03/05/2015WO2015028669A1 Analogues of porphyrins, their method of preparation and use thereof especially in dye-sensitive solar cells
03/05/2015WO2015028662A1 Compositions and methods for characterization and amelioration of rheumatoid arthritis
03/05/2015WO2015028659A1 Composition comprising torasemide and baclofen for treating neurological disorders
03/05/2015WO2015028637A1 Novel drug formulation
03/05/2015WO2015028622A1 Pyrido[4,3-b]pyrazine compounds and compositions
03/05/2015WO2015028574A1 Compound and method for vaccination and immunisation
03/05/2015WO2015028548A1 Multivalent sialic acid derivates
03/05/2015WO2015028522A1 Compositions comprising bacteriostatic agents and brilliant blue g
03/05/2015WO2015028515A1 Cytotoxic t cell response modifiers
03/05/2015WO2015028483A1 Pyrrolopyridine or pyrazolopyridine derivatives
03/05/2015WO2015028473A1 Pharmaceutical composition containing dimethyl fumarate for administration at a low daily dose
03/05/2015WO2015028472A1 Pharmaceutical composition containing dimethyl fumarate for administration at a low daily dose
03/05/2015WO2015028456A1 PPAR modulators
03/05/2015WO2015028427A1 Compounds with pesticidal activity
03/05/2015WO2015028409A1 6,7-dihydro-5h-benzo[7]annulene derivatives, method for the preparation thereof, pharmaceutical preparations comprising them, and the use thereof for producing medicaments
03/05/2015WO2015028286A1 Polymeric synthetic antidote
03/05/2015WO2015028132A1 Beta carotene preparation
03/05/2015WO2015028104A1 Novel drug combination
03/05/2015WO2015028095A1 Branimycin derivatives and their use for the treatment of bacterial infectious diseases
1 2 3 4 5 6 7 8 9 10 11 ... 7860